Home ProductsHot Sales

One-Step Influenza A Test,Cassette/Strip ,Competitive Price

One-Step Influenza A Test,Cassette/Strip ,Competitive Price

    • One-Step Influenza A Test,Cassette/Strip ,Competitive Price
    • One-Step Influenza A Test,Cassette/Strip ,Competitive Price
  • One-Step Influenza A Test,Cassette/Strip ,Competitive Price

    Product Details:

    Place of Origin: CHINA
    Brand Name: SPAN
    Certification: Influenza
    Model Number: Influenza

    Payment & Shipping Terms:

    Minimum Order Quantity: 100 TESTS
    Price: Negotiable
    Packaging Details: 40 tests/box
    Delivery Time: within 3-5 working days(depends on your quantity)
    Payment Terms: T/T, Western Union,Paypal
    Supply Ability: Influenza
    Contact Now
    Detailed Product Description
    Package: Neutral Box: White

    One-Step Influenza A Test

     

    INTENDED USE

    One Step Influenza A Test is a rapid qualitative assay that detects influenza type A (including the subtype H1N1) nucleoprotein antigen extracted from the nasal swab specimen. The device is used to aid in the diagnosis of influenza type A infection.

    For in vitro diagnostic use only. For professional use only.

     

    SUMMARY

    Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease that is easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the autumn and winter months. There are three types of influenza viruses: A, B, and C. Only influenza A viruses are further classified by subtype on the basis of the two main surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Influenza A subtypes and B viruses are further classified by strains.

    Humans can be infected with influenza types A, B, and C viruses. Subtypes of influenza A that are currently circulating among people worldwide include H1N1, H1N2, and H3N2 viruses. Influenza B viruses can cause morbidity and mortality among humans, but in general are associated with less severe epidemics than influenza A viruses. Although influenza type B viruses can cause human epidemics, they have not caused pandemics. Influenza type C viruses cause mild illness in humans and do not cause epidemics or pandemics.

     

    PRINCIPLE

    One Step Influenza A Test is a rapid immunochromatographic test for the visual detection of influenza type A antigen (nucleoprotein) extracted from the nasal swab specimen. The test adopts double antibody sandwich method.

    When the extracted specimen is added into the test device, the specimen is absorbed into the device by capillary action, mixes with antibody-dye conjugate, and flows across the membrane pre-coated with influenza type A monoclonal antibody.

    When the influenza type A antigen levels are at or above the target cutoff (the detection limit of the test), type A antigen in the specimen binds to the specific antibody-dye conjugate and are captured by influenza type A monoclonal antibody immobilized in the relative site of test region “T” of the device. This produces a colored test band in the test region. When the influenza type A antigen levels are zero or below the target cut off, there is not a visible colored band in the test region of the device. This indicates a negative result for influenza type A.

    To serve as a procedure control, a colored line will appear at the control region (C), if the test has been performed properly.

     

    PRECAUTIONS

    1. This kit is for in vitro use only. Do not swallow.
    2. Do not mix components from different kit lots.
    3. Do not use test kit beyond the expiration date.
    4. Do not use the kit if the pouch is punctured or not well sealed.
    5. Keep out of the reach of children.
    6. Discard after use. The test device cannot be used more than once.
    7. The extraction tube and nasal swab are single use items – do not use with multiple specimens.
    8. All specimens should be treated as potentially infectious diseases. Protection glove should be worn when handling the specimen. Wash hands thoroughly afterwards.
    9. Avoid splashing or aerosol formation.
    10. DISPOSAL OF THE DIAGNOSTIC: The used device, swab and extraction tube have the infectious risk. The process of disposing the diagnostic must follow the local infectious disposal law or laboratory rule.

    MATERIAL

    Material provided

    1.20 Individual sealed pouches, each containing

    Test device

    Desiccant pouch

    2. 20 Extraction tubes.

    3.20 Nasal swabs.

    4. Two dropper bottles of extraction buffer (each 5mL): 0.1M phosphate buffer saline (PBS).

    5. Leaflet with instructions for use.

     

    Material Required But Not Provided

    Timer

     

    STORAGE AND STABILITY

    1. Store at 4ºC ~ 30 ºC in the sealed pouch up to the expiration date.
    2. Keep away from sunlight, moisture and heat.
    3. DO NOT FREEZE.

    SPECIMEN COLLECTION AND PREPARATION

    1.Take out the nasal swab provided. Tilt the head of the patient backwards to the angle of 70° and gently insert the nasal swab into the nostril which shows the most secretion.

    2.Very gently rotate and push the swab until resistance is met at level of the turbinate. Gently rotate the swab against the nasal wall for a few times.

    3.Patient samples perform best if tested immediately after collection.

    If immediate testing is not possible, the swab should be placed in a dry, sterile plastic tube (not provided) and stored at 2ºC-4ºC for up to 8 hours.

     

     

    TEST PROCEDURE

     

    Allow the test device, specimen, and extraction buffer to equilibrate to room temperature (10°C ~30°C) prior to testing.

     

    1.Use an extraction tube (provided) for each specimen to be tested, and label each tube appropriately.

    2.Hold the extraction buffer bottle upside down vertically, then add 8 drops (about 400μl) of extraction buffer to the extraction tube.

    3.Place the specimen swab in the tube and swirl the swab for 10 times while pressing the swab head against the inside of the tube to release the specimen in the swab.

    4.Remove the swab while squeezing the swab head against the inside of the collection tube as you remove it to expunge as much liquid as possible from the swab. Discard the swab. Cap the tube and mix contents by gently swirling. The extraction specimen must be tested immediately.

    5.Remove the test device from its sealed foil pouch by tearing at the notch. Dispense 3~4 drops (80μl~100μl) of extraction specimen from the extraction tube into the sample well of the test device by inverting and squeezing the tube as shown.

    6.Read the test results at 15~20 minutes. DO not read test results after 30 minutes.

    One-Step Influenza A Test,Cassette/Strip ,Competitive Price

    INTERPRETATION OF RESULTS

     

    Positive (+)

    Colored bands are visible in both the control region and the test region. It indicates a positive result for influenza type A antigen.

    Negative (-)

    A colored band is visible only in the control region. No color band appears in the test region. It indicates that the concentration of the influenza type A antigen is zero or below the detection limit of the test.

    Invalid

    No visible band at all, or there is a visible band only in the test region but not in the control region. Repeat with a new test kit. 

    One-Step Influenza A Test,Cassette/Strip ,Competitive Price

     

    Note: There is no meaning attributed to line color intensity or width.

     

    QUALITY CONTROL

    A procedural control is included in the test. A colored line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.

    Good laboratory practice recommends the use of the control materials. Users should follow the appropriate federal state, and local guidelines concerning the frequency of assaying external quality control materials.

     

    LIMITATIONS OF PROCEDURE

    1.This test has been developed for testing nasal swab specimen only.

    2.As it is with any diagnostic procedure, a confirmed diagnosis should only be made after all clinical and laboratory findings have been evaluated.

    3.A negative test result may occur if the level of antigen in a sample is below the detection limit of the test, or from improper sample collection.

    4.Negative test results are not intended to rule-out other non-influenza viral infections.

    5.Positive test results do not rule out co-infections with other pathogens and does not identify specific influenza A virus subtypes.

     

    PERFORMANCE CHARACTERISTICS

     

    The lowest detectable limit

    For influenza type A : 5.1×105TCID50/ml

     

    Accuracy

    A comparison study of One Step Influenza A Test and another commercial influenza test (Colloidal gold method) was carried out in several medical institutions. Nasal swab samples were collected from adult and child patients exhibiting influenza-like symptoms. One swab was used to perform the One Step Influenza A Test and one swab was used for another commercial influenza test analysis.

    Compare the sensitivity and specificity between the two tests. The results are summarized in Table 1.

    Table 1: Comparison results

     

    One Step Influenza A Test The reference test Total
    Influenza A positive Influenza A negative
    Influenza A positive 284 37 321
    Influenza A negative 27 745 772
    Total 311 782 1093

    (1) Sensitivity of One Step Influenza A Test is: 284/311×100%=91.3%

    (2) Specificity of One Step Influenza A Test is: 745/782×100%=95.7%

     

    Analytical reactivity

    One Step Influenza A Test was tested with the following influenza A viral strains listed in Table 2. All showed positive results. Although the specific influenza A strains causing infection in humans can vary year to year, all contain the conserved nucleoproteins targeted by the One Step Influenza A Test.

    Table 2: Influenza A viral trains

    Influenza type A
    A/14160 (H1N1)
    A/MEN30(H1N1)
    A/22130(H1N1)
    A/2361(H1N1)
    A/44045 (H3N2)
    A/924 (H3N2)
    H3/05-349
    A/Beijing/302/54 (H5N1)
    A/swine/Guangdong/2/01(H1N1)

     

     

     

    Rebecca Yan

     

    Tel: +86(755)89589611

    Fax: +86(755)89580096

    Cell Phone:+8613417551798(WhatsApp)

     

    Contact Details
    SPAN BIOTECH LTD.

    Contact Person: Ms. Anna Lee

    Tel: 86-755-89589611

    Fax: 86-755-89580096

    Send your inquiry directly to us (0 / 3000)